OKYO Pharma (OKYO) Other Non-Current Liabilities (2023 - 2025)

OKYO Pharma (OKYO) has 3 years of Other Non-Current Liabilities data on file, last reported at $93748.0 in Q3 2025.

• Other Non-Current Liabilities for Q3 2025 came in at $93748.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $93748.0 (changed 0.0% YoY), and the FY2025 annual result was $93748.0, changed 0.0% from the prior year.
• Other Non-Current Liabilities steadied at $93748.0 in Q3 2025 per OKYO's latest filing, from $93748.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $93748.0 in Q1 2024 and troughed at $89956.0 in Q3 2023.
• A 3-year average of $92989.6 and a median of $93748.0 in 2024 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities climbed 4.22% in 2024, then changed 0.0% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $89956.0 in 2023, then increased by 4.22% to $93748.0 in 2024, then changed by 0.0% to $93748.0 in 2025.
• Business Quant data shows OKYO's Other Non-Current Liabilities at $93748.0 in Q3 2025, $93748.0 in Q1 2025, and $93748.0 in Q3 2024.